Alerts will be sent to your verified email
Verify Email
VILINBIO
|
Vilin Bio Med
|
Unick Fix-A-Form
|
Guj. Terce Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.09 % | 9.15 % | -11.74 % |
|
5yr average Equity Multiplier
|
1.6 | 2.49 | 3.3 |
|
5yr Average Asset Turnover Ratio
|
0.68 | 0.88 | 1.76 |
|
5yr Avg Net Profit Margin
|
2.8 % | 4.16 % | -2.57 % |
|
Price to Book
|
1.52 | 1.05 | 5.25 |
|
P/E
|
154.79 | 13.91 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
211.9 Days | 21.15 Days | -20.6 Days |
|
Inventory Days
|
70.76 Days | 48.34 Days | 40.01 Days |
|
Days Receivable
|
147.75 Days | 79.56 Days | 39.02 Days |
|
Days Payable
|
44.01 Days | 119.31 Days | 100.7 Days |
|
5yr Average Interest Coverage Ratio
|
1.77 | 2.62 | 1.07 |
|
5yr Avg ROCE
|
8.99 % | 12.8 % | 3.46 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 14.14 % | -0.49 % |
|
5 yr average Debt to Equity
|
0.47 | 0.86 | 0.63 |
|
5yr CAGR Net Profit
|
12.89 % | -7.47 % | -17.21 % |
|
5yr Average Return on Assets
|
1.89 % | 3.64 % | -3.57 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.89 % | 71.57 % | 37.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.63 % | 35.92 % | 0.81 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vilin Bio Med
|
Unick Fix-A-Form
|
Guj. Terce Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|